Impact of endothelin blockade on acute exercise‐induced changes in blood flow and endothelial function in type 2 diabetes mellitus

• Published in: Experimental physiology Vol. 99; no. 9; pp. 1253 - 1264
• Main Authors: Schreuder, Tim H. A., Lotringen, Jaap H., Hopman, Maria T. E., Thijssen, Dick H. J.
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.09.2014
• Subjects: Aged; Blood Flow Velocity; Brachial Artery - drug effects; Brachial Artery - metabolism; Brachial Artery - physiopathology; Cross-Over Studies; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - diagnosis; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - physiopathology; Double-Blind Method; Endothelin Receptor Antagonists - administration & dosage; Endothelium, Vascular - drug effects; Endothelium, Vascular - metabolism; Endothelium, Vascular - physiopathology; Exercise; Hand Strength; Humans; Male; Middle Aged; Netherlands; Regional Blood Flow; Sulfonamides - administration & dosage; Time Factors; Treatment Outcome; Vasodilation - drug effects; Netherlands
• ISSN: 0958-0670; 1469-445X
• DOI: 10.1113/expphysiol.2013.077297

New Findings What is the central question of this study? Doesendothelin receptor blockade increase exercise‐induced blood flow and post‐exercise endothelial function in men with type 2 diabetes? What is the main finding and its importance? Despite increasing exercise‐induced blood flow, endothelin receptor blockade did not impact post‐exercise endothelial function. The increase in blood flow may have beneficial effects in repeated exercise training. Positive vascular effects of exercise training are mediated by acute increases in blood flow. Type 2 diabetes patients show attenuated exercise‐induced increases in blood flow, possibly mediated by the endothelin pathway, preventing an optimal stimulus for vascular adaptation. We examined the impact of endothelin receptor blockade (bosentan) on exercise‐induced blood flow in the brachial artery and on pre‐ and postexercise endothelial function in type 2 diabetes patients (n = 9, 60 ± 7 years old) and control subjects (n = 10, 60 ± 5 years old). Subjects reported twice to the laboratory to perform hand‐grip exercise in the presence of endothelin receptor blockade or placebo. We examined brachial artery endothelial function (via flow‐mediated dilatation) before and after exercise, as well as blood flow during exercise. Endothelin receptor blockade resulted in a larger increase in blood flow during exercise in type 2 diabetes patients (P = 0.046), but not in control subjects (P = 0.309). Exercise increased shear rate across the exercise protocol, unaffected by endothelin receptor blockade. Exercise did not alter brachial artery diameter in either group, but endothelin receptor blockade resulted in a larger brachial artery diameter in type 2 diabetes patients (P = 0.033). Exercise significantly increased brachial artery flow‐mediated dilatation in both groups, unaffected by endothelin receptor blockade. Endothelin receptor blockade increased exercise‐induced brachial artery blood flow in type 2 diabetes patients, but not in control subjects. Despite this effect of endothelin receptor blockade on blood flow, we found no impact on baseline or post‐exercise endothelial function in type 2 diabetes patients or control subjects, possibly related to normalization of the shear stimulus during exercise. The successful increase in blood flow during exercise in type 2 diabetes patients through endothelin receptor blockade may have beneficial effects in repeated exercise training.